PaxVax, Inc. Expands Executive Management Team
Published: Feb 09, 2012
MENLO PARK, Calif.--(BUSINESS WIRE)--PaxVax Corporation, developer of innovative and socially responsible oral vaccines against infectious diseases, announced the expansion of its executive management team with the appointments of Nima Farzan as Executive Vice President and Chief Operating Officer, Thomas P. Monath, M.D. as Chief Technology Officer, and Jonathan F. Smith, Ph.D. as Executive Vice President and Chief Scientific Officer.